Decreased Release of the Angiogenic Peptide Vascular Endothelial Growth Factor in Alzheimer’s Disease: Recovering Effect with Insulin and DHEA Sulfate

Publisher： Karger

E-ISSN： 1421-9824|19|1|1-10

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.19, Iss.1, 2004-12, pp. : 1-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Decreased Plasma Insulin-Like Growth Factor-I Level in Familial Alzheimer’s Disease Patients Carrying the Swedish APP 670/671 Mutation

By  

Dementia and Geriatric Cognitive Disorders, Vol. 10, Iss. 6, 1999-11 ,pp. : 446-451

Karger

Access to resources Recommend Favorite

Intrathecal Release of Nitric Oxide in Alzheimer’s Disease and Vascular Dementia

By  

Dementia and Geriatric Cognitive Disorders, Vol. 11, Iss. 6, 2000-10 ,pp. : 322-326

Karger

Access to resources Recommend Favorite

Role of Vascular Endothelial Growth Factor in Kidney Disease

By  

Current Vascular Pharmacology, Vol. 8, Iss. 1, 2010-01 ,pp. : 122-128

Bentham Science Publishers

Access to resources Recommend Favorite

Intracerebroventricular Infusion of Nerve Growth Factor in Three Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 9, Iss. 5, 1998-08 ,pp. : 246-257

Karger

Access to resources Recommend Favorite

Placental growth by the estrogen-dependent angiogenic factors, vascular endothelial growth factor and basic fibroblast growth factor, throughout gestation

By Nakagawa Y   Fujimoto J   Tamaya T  

Gynecological Endocrinology, Vol. 19, Iss. 5, 2004-11 ,pp. : 259-266

Informa Healthcare

Access to resources Recommend Favorite